Your browser doesn't support javascript.
Risankizumab effectiveness and safety in psoriasis patients who failed other biologics: Real-life case series.
Dawoud, Noha Mohammed; El Badawy, Maha Bedair; Al Eid, Hala Subhi; Abdel Fattah, Moataz M.
  • Dawoud NM; Department of Dermatology, Andrology and STDs, Faculty of Medicine, Menoufia University, Al Minufiyah, Egypt.
  • El Badawy MB; Department of Dermatology, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
  • Al Eid HS; Department of Clinical Pharmacy, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
  • Abdel Fattah MM; Department of Research Administration, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Indian J Dermatol Venereol Leprol ; 88(2): 235-240, 2022.
Article in English | MEDLINE | ID: covidwho-1772101
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / Biological Products / Antibodies, Monoclonal Type of study: Experimental Studies Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Indian J Dermatol Venereol Leprol Year: 2022 Document Type: Article Affiliation country: IJDVL_510_2021

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / Biological Products / Antibodies, Monoclonal Type of study: Experimental Studies Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Indian J Dermatol Venereol Leprol Year: 2022 Document Type: Article Affiliation country: IJDVL_510_2021